isoproterenol and pimagedine

isoproterenol has been researched along with pimagedine in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (41.67)18.2507
2000's4 (33.33)29.6817
2010's3 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Coston, AF; Klabunde, RE1
Fedan, JS; Frazer, DG; Robinson, Va; Warner, TE; Yuan, LX1
Bloch, KD; Holzmann, A; Manktelow, C; Taut, FJ; Zapol, WM1
Gaballa, MA; Goldman, S; Hoover, CA; Raya, TE1
Conrad, N; Kornberg, A; Reichart, B; Schulze, C; Weismueller, S; Wildhirt, SM1
Ikeda, U; Kurosaki, K; Maeda, Y; Shimada, K1
Ahmadi, SH; Dehghani, M; Dehpour, AR; Ebrahimi, F; Hajrasouliha, AR; Sadeghipour, H; Tavakoli, S1
Dai, DZ; Dai, Y; Li, N; Xu, J; Yu, F1
Cheng, YS; Dai, DZ; Dai, Y1
Dinda, AK; Maulik, SK; Prabhakar, P; Seth, S1
Balaji, N; Devi K M, S; Gopi, V; Parthasarathy, A; Vellaichamy, E1

Other Studies

12 other study(ies) available for isoproterenol and pimagedine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Nitric oxide synthase inhibition does not prevent cardiac depression in endotoxic shock.
    Shock (Augusta, Ga.), 1995, Volume: 3, Issue:1

    Topics: Amino Acid Oxidoreductases; Animals; Arginine; Cardiac Output, Low; Dexamethasone; Guanidines; Heart Rate; Hemodynamics; Hypotension; Isoproterenol; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Sprague-Dawley; Shock, Septic

1995
Nitric oxide synthase inhibitor and lipopolysaccharide effects on reactivity of guinea pig airways.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 272, Issue:3

    Topics: Airway Resistance; Amino Acid Oxidoreductases; Animals; Arginine; Epithelium; Guanidines; Guinea Pigs; Histamine; In Vitro Techniques; Isoproterenol; Lipopolysaccharides; Male; Methacholine Chloride; Methylene Blue; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Penicillamine; Respiration; S-Nitroso-N-Acetylpenicillamine; Trachea

1995
Inhibition of nitric oxide synthase prevents hyporesponsiveness to inhaled nitric oxide in lungs from endotoxin-challenged rats.
    Anesthesiology, 1999, Volume: 91, Issue:1

    Topics: Administration, Inhalation; Animals; Dexamethasone; Enzyme Inhibitors; Guanidines; Isoproterenol; Lipopolysaccharides; Lung; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Perfusion; Rats; Rats, Sprague-Dawley

1999
Effects of endothelial and inducible nitric oxide synthases inhibition on circulatory function in rats after myocardial infarction.
    Cardiovascular research, 1999, Volume: 42, Issue:3

    Topics: Adrenergic beta-Agonists; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanidines; Hemodynamics; Isoproterenol; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley

1999
Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury.
    Cardiovascular research, 1999, Aug-15, Volume: 43, Issue:3

    Topics: Adrenergic beta-Agonists; Animals; Enzyme Activation; Enzyme Inhibitors; Guanidines; Hemodynamics; Infusions, Intravenous; Injections, Intravenous; Isoproterenol; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rabbits; Random Allocation; Time Factors; Ventricular Function, Left

1999
Carvedilol stimulates nitric oxide synthesis in rat cardiac myocytes.
    Journal of molecular and cellular cardiology, 2000, Volume: 32, Issue:2

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Atenolol; Carbazoles; Carvedilol; Dactinomycin; Drug Synergism; Enzyme Induction; Enzyme Inhibitors; Guanidines; Heart; Interleukin-1; Isoproterenol; Muscle Proteins; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Nucleic Acid Synthesis Inhibitors; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Recombinant Proteins

2000
Involvement of endogenous opioid peptides and nitric oxide in the blunted chronotropic and inotropic responses to beta-adrenergic stimulation in cirrhotic rats.
    Fundamental & clinical pharmacology, 2006, Volume: 20, Issue:5

    Topics: Adrenergic beta-Agonists; Animals; Bile Ducts; Enzyme Inhibitors; Guanidines; Heart Atria; In Vitro Techniques; Isoproterenol; Ligation; Liver Cirrhosis, Biliary; Male; Muscle Contraction; Naltrexone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Opioid Peptides; Papillary Muscles; Rats; Rats, Sprague-Dawley

2006
The endothelin receptor antagonist CPU0213 is more effective than aminoguanidine to attenuate isoproterenol-induced vascular abnormality by suppressing overexpression of NADPH oxidase [correction of oxidas], ETA, ETB, and MMP9 in the vasculature.
    Journal of cardiovascular pharmacology, 2008, Volume: 52, Issue:1

    Topics: Animals; Aorta, Thoracic; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Guanidines; In Vitro Techniques; Isoproterenol; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; NADPH Oxidases; Nitric Oxide Synthase Type II; Oxidative Stress; Pyrazoles; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger; Up-Regulation

2008
Isoproterenol disperses distribution of NADPH oxidase, MMP-9, and pPKCepsilon in the heart, which are mitigated by endothelin receptor antagonist CPU0213.
    Acta pharmacologica Sinica, 2009, Volume: 30, Issue:8

    Topics: Animals; Cardiotonic Agents; Endothelin Receptor Antagonists; Gene Expression Regulation; Guanidines; Heart; Hypertrophy; Isoproterenol; Male; Matrix Metalloproteinase 9; Myocardium; NADPH Oxidases; Nitric Oxide Synthase; Protein Kinase C-epsilon; Pyrazoles; Rats; Rats, Sprague-Dawley

2009
Genistein prevents isoproterenol-induced cardiac hypertrophy in rats.
    Canadian journal of physiology and pharmacology, 2012, Volume: 90, Issue:8

    Topics: Animals; Cardiomegaly; Cardiotonic Agents; Catalase; Disease Models, Animal; Enzyme Inhibitors; Fibrosis; Genistein; Glutathione; Guanidines; Hydroxyproline; Isoproterenol; Male; Myocardium; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances

2012
Aminoguanidine inhibits ventricular fibrosis and remodeling process in isoproterenol-induced hypertrophied rat hearts by suppressing ROS and MMPs.
    Life sciences, 2014, Nov-18, Volume: 118, Issue:1

    Topics: Animals; Antioxidants; Cardiomegaly; Fibrosis; Guanidines; Heart Ventricles; Isoproterenol; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Rats, Wistar; Reactive Oxygen Species; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transcription Factor RelA; Ventricular Remodeling

2014